Skip to search formSkip to main contentSkip to account menu

Soluble Tumor Necrosis Factor Receptor Measurement

Known as: Soluble Tumor Necrosis Factor Receptor, TNFR Measurement, TNFSR 
The determination of the amount of soluble tumor necrosis factor receptor present in a sample.
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Biomarkers of inflammation and progression of chronic kidney disease.
BACKGROUND Chronic kidney disease is associated with higher levels of inflammatory biomarkers. Statins have anti-inflammatory… 
Highly Cited
2002
Highly Cited
2002
Local production of complement proteins in rheumatoid arthritis synovium.
OBJECTIVE Complement has been repeatedly implicated in the pathogenesis of rheumatoid arthritis (RA) based on studies showing… 
Highly Cited
2000
Highly Cited
2000
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
OBJECTIVE To determine the potential for additive or synergistic effects of combination therapy with the recombinant anticytokine… 
Highly Cited
1996
Highly Cited
1996
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis.
OBJECTIVE To determine the safety and pharmacokinetics of recombinant human tumor necrosis factor receptor (p80) fusion protein… 
Highly Cited
1995
Highly Cited
1995
Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I
Highly Cited
1994
Highly Cited
1994
Intratracheal administration of endotoxin and cytokines. VII. The soluble interleukin-1 receptor and the soluble tumor necrosis factor receptor II (p80) inhibit acute inflammation.
Intratracheal administration of endotoxin (LPS) causes acute neutrophilic inflammation via induction of pulmonary tumor necrosis… 
Highly Cited
1994
Highly Cited
1994
Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram- negative sepsis
The aim of this study was to compare the ability of both a 55- and 75- kD soluble tumor necrosis factor receptor immunoglobulin G… 
Highly Cited
1993
Highly Cited
1993
Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice.
A recombinant human TNF receptor Fc fusion protein (rhuTNFR:Fc) was assessed for antiarthritic activity using murine type II… 
Highly Cited
1993
Highly Cited
1993
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
OBJECTIVE To determine the value of measurement of serum soluble tumor necrosis factor receptor (sTNFR), compared with… 
Highly Cited
1991
Highly Cited
1991
Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethality
The in vivo efficacy of human recombinant soluble tumor necrosis factor (TNF) receptor protein to prevent and to treat… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)